Purchase Order 959P0020P0010
- Not listed
- The Department of the Navy Bureau of Medicine and Surgery awarded a $3,741.80 firm fixed price delivery order contract to Microgenics Corporation for cannabinoid (THC) immunoassay reagent. Microgenics Corporation, a division of Thermo Electron Corporation, will deliver the requested cannabinoid test reagents from its Fremont, California facility to support the Department of the Navy's drug testing program. No set-aside provisions were specified in this contract award to Microgenics...
- This federal contract award, W91YTZ20P0306, was issued by the Department of Defense Medical Command (MEDCOM) to Microgenics Corporation, a subsidiary of Thermo Electron Corporation. The $81,399.60 firm-fixed-price purchase order is for the supply of clinical diagnostic products and toxicology testing solutions, specifically reagent kits for detecting controlled substances like opiates, benzodiazepines, and MDMA/MDA. This contract is not designated as a set-aside. Microgenics Corporation, the...
- The NIH Clinical Center issued a purchase order to Microgenics Corporation on July 24, 2015, for $15,552.33 with an ultimate completion date of March 30, 2021. The order is firm fixed-price with no set-aside designation. Place of performance is Bethesda, Maryland. The purchase order procures immunoassay reagent test kits for clinical toxicology screening, a core product line within Microgenics' Clinical Diagnostics Division. Microgenics is a subsidiary of Thermo Electron Corporation and operates...
- The U.S. Navy Bureau of Medicine and Surgery awarded a $5,423.20 firm fixed-price delivery order to Microgenics Corporation for opiate immunoassay reagent kits in support of the Drug Demand Reduction Program. The contract, with an ultimate completion date of October 17, 2025, represents a continuation of the agency's ongoing procurement of specialized diagnostic testing supplies. Microgenics Corporation, a clinical diagnostics manufacturer based in Fremont, California, and a subsidiary of Thermo...
- Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation, has been awarded a firm fixed price delivery order valued at $22,560.20 from the Defense Health Agency. The order is being issued under an indefinite-delivery contract vehicle to provide opiates reagent kits in support of substance abuse testing and treatment programs across military medical facilities. Performance will take place in Fremont, California through August 2023. As a long-time supplier of...
- The Defense Health Agency has awarded a firm fixed price delivery order valued at $15,618.60 to Microgenics Corporation for the provision of opiate reagent kits at Tripler Army Medical Center in Hawaii. Microgenics, a clinical diagnostics division of Thermo Electron Corporation, will fulfill the contract from its location in Fremont, California. As a subsidiary of Thermo Electron Corporation, Microgenics can leverage its parent company's financial and contracting resources. The delivery order...
- This federal contract award was made by the Air Education and Training Command (AETC), a defense agency, to Microgenics Corporation, a subsidiary of Thermo Electron Corporation. The $16,269.60 firm fixed-price delivery order is for the supply of opiates reagent kits. The award is not associated with any set-aside designations. Microgenics Corporation is a clinical diagnostics manufacturer that specializes in providing laboratory reagents, test kits, and diagnostic equipment to support federal...
- This federal contract award is for the provision of DRI OPIATE 500 ML REAGENT TEST KITS to the Bureau of Medicine and Surgery, a component of the Department of Defense. The contract was awarded to Microgenics Corporation, a subsidiary of Thermo Electron Corporation, as a firm-fixed price delivery order against an existing indefinite delivery vehicle. The contract has a ceiling value of $8,134.80 and a period of performance through August 28, 2024. Microgenics Corporation is a manufacturer of...
- This federal contract award is for the delivery of BENZODIAZEPINE REAGENT KITS to the Bureau of Medicine and Surgery, a defense agency. The $58,568.40 firm fixed-price contract was awarded to Microgenics Corporation, a subsidiary of Thermo Electron Corporation that specializes in manufacturing clinical diagnostic products and toxicology testing solutions. The contract has a performance period through July 2025 and does not have a set-aside designation, indicating Microgenics' competitive...
- Microgenics Corporation, a clinical diagnostics division of Thermo Electron Corporation, has received a $10,412.40 firm fixed price delivery order from the Defense Health Agency to provide NEW- DRI OPIATES IMMUNOASSAY. The order is being performed under an existing contract vehicle without a set-aside designation. It will support substance abuse testing and treatment programs across military medical facilities by supplying opiate immunoassay reagent test kits for use in laboratories located at...
On May 12, 2020, the Court and Community Supervision Services (CSOSA) Pretrial Services Agency awarded a $225,000 firm fixed-price purchase order to Microgenics Corporation for phencyclidine (PCP) immunoassay reagents, calibrators, and quality control materials designated for THC 40 and THC 60 testing applications. The contract was solicited through a special notice posted on February 26, 2020, with a submission deadline of March 5, 2020, and is scheduled for ultimate completion by May 11, 2025. As a civilian agency contract, this award supports CSOSA's pretrial services operations in Washington, DC, with no set-aside designation applied. Microgenics Corporation, a subsidiary of Thermo Electron Corporation and a established federal contractor specializing in clinical diagnostic products, is well-positioned to fulfill this requirement through its Clinical Diagnostics Division. The company has demonstrated sustained success in delivering immunoassay reagent test kits to federal agencies, particularly the Department of Defense and Department of Veterans Affairs, supporting substance abuse testing and treatment programs. Through multiple indefinite delivery contracts valued at several million dollars collectively, Microgenics supplies critical diagnostic reagents across a range of controlled substance detection applications, underscoring its capability to deliver specialized toxicology testing solutions to support CSOSA's pretrial drug screening operations.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Phencyclidine (PCP) Immunoassay Reagents, Calibrators, Quality Control & Marijuana (THC) | 959P0020Q0014 | Pretrial Services Agency | Special Notice 1/1 | 2/26/20, 10:38 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00006 | Other Administrative Action | ($20k) | 9/29/25 | |
| P00005 | Exercise an Option | $45.0k | 4/13/23 | |
| P00004 | Funding Only Action | $11.3k | 2/13/23 | |
| P00003 | Other Administrative Action | $0 | 4/22/22 | |
| P00002 | Funding Only Action | $11.3k | 4/21/22 |